Monograph Details
|
|
Dermatological Disorders
> Skin infections (topicals)
|
|
NAFTIN |
| Manufacturer |
|
Merz Pharmaceuticals |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Allylamine antifungal. |
| Generic Name |
|
Naftifine HCl 1%; crm; gel. |
| Indications |
|
Tinea pedis, t. cruris, t. corporis. |
| Children |
|
Not recommended. |
| Adults |
|
Crm: apply daily. Gel: apply twice daily. If no improvement within 4 wks, discontinue and reevaluate. Wash hands after application. |
| Precautions |
|
Discontinue if irritation occurs. Confirm diagnosis with KOH smear and/or culture. Avoid occlusive dressings, mucous membranes. Pregnancy (Cat.B). Nursing mothers. |
| Adverse Reactions |
|
Burning, stinging, dryness, erythema, itching, local irritation. |
| How Supplied |
Crm—15g, 30g, 60g
Gel—20g, 40g, 60g |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
